Comparison of hemodynamic effects of anti-arrhythmic agents. I. Ajmaline and procaine amide
Mibuyamba, P.; Lisin, N.; Carlier, J.
Acta Cardiologica 26(4): 365-380
1971
ISSN/ISBN: 0001-5385 PMID: 5316295 Document Number: 31019
Document emailed within 1 workday
Related Documents
Libersa, C.; Caron, J.; Guedon-Moreau, L.; Lacroix, D. 1992: Pro-arrhythmic effects of anti-arrhythmic agents. Study methods and difficulties in analysis Therapie 47(5): 363-365Weiss-Simon, C.; Spangenberg, G.; Michel, D. 1980: Anti-arrhythmic agents. 2. Special anti-arrhythmic effect, known drug interactions Fortschritte der Medizin 98(15): 569-572
Haverkamp, W.; Wichter, T.; Chen, X.; Hördt, M.; Willems, S.; Rotman, B.; Hindricks, G.; Kottkamp, H.; Borggrefe, M.; Breithardt, G. 1994: The pro-arrhythmic effects of anti-arrhythmia agents Zeitschrift für Kardiologie 83(Suppl 5): 75-85
Lotto, A.; Finzi, A. 1986: Evaluation of the hemodynamic effects and anti-arrhythmic activity of propafenone: from new frontiers to clinical verification Giornale Italiano di Cardiologia 16(4): 333-335
Dreifus, L.S. 1970: Use of anti-arrhythmic agents other than digitalis South Dakota Journal of Medicine 23(2): 17-19
Wellens, D.; Casulo, A.; Van Remoortere, E.C. 1970: Anti-arrhythmic agents and sympathetic stimulation of the vas deferens Journal de Physiologie 62(Suppl 3): 464-465
Koch-Weser, J. 1974: Clinical application of the pharmacokinetics of procaine amide Cardiovascular Clinics 6(2): 63-75
Mashiba, H.; Kanaya, S. 1974: Actions of anti-arrhythmic agents on physiology of myocardial cell membrane Nihon Rinsho. Japanese Journal of Clinical Medicine 32(9): 2829-2834
Caramella, J.P.; Guerot, C.; Valere, P.E.; Tricot, R.; Bismuth, C.; Riboulet, G. 1982: Cardiac toxicity of ajmaline. Comparison of acute voluntary poisoning with complications of the ajmaline test Archives des Maladies du Coeur et des Vaisseaux 75(5): 613-620
Nick, J.; Combrisson, A.; Reignier, A.; Verdy, E.; Gally, A.M.; Bakouche, P.; Dudognon, P.; Dray, C. 1978: Iatrogenic procaine amide-induced lupus with circulating anticoagulant Annales de Medecine Interne 129(4): 259-263
Chichkanov, G.G.; Tsorin, I.B.; Kirsanova, G.I.; Berdiaev, S.I.; Turilova, A.I. 1997: Anti-arrhythmic properties of specific bradycardic agents from the group of 2-mercaptobenzimidazole derivatives Eksperimental'naia i Klinicheskaia Farmakologiia 60(5): 35-39
Korkushko, O.V.; Shatilo, V.B.; Moroz, G.Z.; Shatilo, T.V. 1989: Anti-arrhythmic effectiveness and hemodynamic effect of ethacizine in middle-aged and elderly patients with ischemic heart disease and extrasystole Klinicheskaia Meditsina 67(3): 74-78
Paparella, N.; Pirani, R.; Cappato, R.; Candini, G.C.; Alboni, P. 1986: Method for differentiating in humans the direct effects of anti-arrhythmic drugs from those mediated by the autonomic nervous system. Effects of quinidine and propafenone Giornale Italiano di Cardiologia 16(9): 762-769
Fossati, C. 1985: Collateral effects of an anti-arrhythmic agent: amiodarone La Clinica Terapeutica 114(6): 509-514
Jaillon, P.; Simon, T. 1992: Ventricular pro-arrhythmic effects of anti-arrhythmia drugs Therapie 47(3): 187-192
Forfang, K.; Lippestad, C.T. 1971: Adverse effects of lidocaine as an anti-arrhythmic drug Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 91(10): 710-713
Dong, Y.L.; Chen, W.Z.; Ding, G.S. 1981: Comparison of arrhythmic effects of aconitine and its 5 analogues Zhongguo Yao Li Xue Bao 2(3): 173-176
Fujita, T.; Miyazaki, M. 1972: Clinical evaluation of beta-receptor blockers in anesthesia. 4. Anti-arrhythmic effects of Y-6124 Masui. Japanese Journal of Anesthesiology 21(5): 450-457
Laubie, M.; Cheymol, G.; Mouillé, P.; Gilbert, J.C.; Schmitt, H. 1973: Anti-arrhythmic effects of a beta-adrenolytic agent dl (hydroxy 2't-butylamino-3' propyloxy) 8-thiochromane (S 2395) Archives Internationales de Pharmacodynamie et de Therapie 201(2): 323-333
Ezer, E.; Szporny, L. 1981: Comparison of the effects of solium salicylate with anti-ulcer agents in preventing indomethacin-induced intestinal ulcer Journal of Pharmacy and Pharmacology 33(4): 250-251